BioSpace News Archive

While a majority of adults recognize leukemia as a blood cancer, a new survey* by The Leukemia & Lymphoma Society (LLS) found that a low percentage of respondents associate the following diseases with a blood cancer: lymphoma (including Hodgkin’s lymphoma), myeloma, myelodysplastic syndromes (MDS), and myeloproliferative neoplasms (MPNs).

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) announced that the Company’s Special Meeting of Stockholders (the “Special Meeting”) held on August 31, 2023 at 9:00 a.m.

According to Precedence Research, the global biotechnology market was valued at USD 1,224.31 billion in 2022

Medivir AB announced that it will host a key opinion leader webcast on the current and future HCC treatment landscape, including how treatment challenges and needs in HCC differs from most other cancers.

United Therapeutics Corporation announced that James Edgemond, Chief Financial Officer and Treasurer, will provide an overview and update on the company’s business during a fireside chat session at the Morgan Stanley 21st Annual Global Healthcare Conference in New York City.

Longaevus Technologies, announces the spin-off of Elastin Biosciences following breakthrough preclinical results of 3 of its assets.

Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, announced that it will be presenting at the Wells Fargo Healthcare Conference being held September 6 -8 in Boston.

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events.

Innovac Therapeutics, an mRNA therapeutics company, announced the completion of an $18 million Series Pre-A financing.

Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced it has completed its previously announced merger with NuVasive, Inc.